These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2983321)

  • 21. Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides.
    Emini EA; Jameson BA; Wimmer E
    Nature; 1983 Aug 25-31; 304(5928):699-703. PubMed ID: 6310403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of neutralizing antibodies by synthetic peptides representing the C terminus of coxsackievirus A9 capsid protein VP1.
    Pulli T; Roivainen M; Hovi T; Hyypiä T
    J Gen Virol; 1998 Sep; 79 ( Pt 9)():2249-53. PubMed ID: 9747735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of site and mode of expression of a heterologous antigenic determinant on the properties of poliovirus hybrids.
    Murdin AD; Mirzayan C; Kameda A; Wimmer E
    Microb Pathog; 1991 Jan; 10(1):27-37. PubMed ID: 1713280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and characterization of a cross-neutralization epitope of Enterovirus 71.
    Liu CC; Chou AH; Lien SP; Lin HY; Liu SJ; Chang JY; Guo MS; Chow YH; Yang WS; Chang KH; Sia C; Chong P
    Vaccine; 2011 Jun; 29(26):4362-72. PubMed ID: 21501643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a poliovirus neutralization epitope through use of neutralizing antiserum raised against a purified viral structural protein.
    Emini EA; Dorner AJ; Dorner LF; Jameson BA; Wimmer E
    Virology; 1983 Jan; 124(1):144-51. PubMed ID: 6186073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical role of neighbouring sequences on the immunogenicity of the C3 poliovirus neutralization epitope expressed at the surface of recombinant bacteria.
    van der Werf S; Charbit A; Leclerc C; Mimic V; Ronco J; Girard M; Hofnung M
    Vaccine; 1990 Jun; 8(3):269-77. PubMed ID: 1694613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptides derived from the unique region of B19 parvovirus minor capsid protein elicit neutralizing antibodies in rabbits.
    Anderson S; Momoeda M; Kawase M; Kajigaya S; Young NS
    Virology; 1995 Jan; 206(1):626-32. PubMed ID: 7530397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of humoral response to a 12-amino-acid site on the poliovirus virion.
    Icenogle JP; Minor PD; Ferguson M; Hogle JM
    J Virol; 1986 Oct; 60(1):297-301. PubMed ID: 3018295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies against the chemically synthesized genome-linked protein of poliovirus react with native virus-specific proteins.
    Baron MH; Baltimore D
    Cell; 1982 Feb; 28(2):395-404. PubMed ID: 6174242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutralization epitopes on poliovirus type 3 particles: an analysis using monoclonal antibodies.
    Ferguson M; Minor PD; Magrath DI; Qui YH; Spitz M; Schild GC
    J Gen Virol; 1984 Jan; 65 ( Pt 1)():197-201. PubMed ID: 6198447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the antibodies elicited by the individual structural polypeptides of foot-and mouth disease and polio viruses.
    Meloen RH; Rowlands DJ; Brown F
    J Gen Virol; 1979 Dec; 45(3):761-3. PubMed ID: 94352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of a foreign epitope on the surface of the adenovirus hexon.
    Crompton J; Toogood CI; Wallis N; Hay RT
    J Gen Virol; 1994 Jan; 75 ( Pt 1)():133-9. PubMed ID: 7509367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross antigenicity among enteroviruses as revealed by immunoblot technique.
    Mertens T; Pika U; Eggers HJ
    Virology; 1983 Sep; 129(2):431-42. PubMed ID: 6312682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence that Equine rhinitis A virus VP1 is a target of neutralizing antibodies and participates directly in receptor binding.
    Warner S; Hartley CA; Stevenson RA; Ficorilli N; Varrasso A; Studdert MJ; Crabb BS
    J Virol; 2001 Oct; 75(19):9274-81. PubMed ID: 11533189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies against a synthetic peptide of the poliovirus replicase protein: reaction with native, virus-encoded proteins and inhibition of virus-specific polymerase activities in vitro.
    Baron MH; Baltimore D
    J Virol; 1982 Sep; 43(3):969-78. PubMed ID: 6292474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attachment of neutralizing antibodies stabilizes the capsid of poliovirus against uncoating.
    Wetz K
    Virology; 1993 Feb; 192(2):465-72. PubMed ID: 8380661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of serotype-specific and nonserotype-specific B-cell epitopes of coxsackie B virus using synthetic peptides.
    Haarmann CM; Schwimmbeck PL; Mertens T; Schultheiss HP; Strauer BE
    Virology; 1994 May; 200(2):381-9. PubMed ID: 7513917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of neutralizing antibodies by all three structural poliovirus polypeptides.
    Dernick R; Heukeshoven J; Hilbrig M
    Virology; 1983 Oct; 130(1):243-6. PubMed ID: 6314647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for conformational changes of poliovirus precursor particles during virus morphogenesis.
    Wiegers KJ; Dernick R
    J Gen Virol; 1985 May; 66 ( Pt 5)():1037-44. PubMed ID: 2582079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature.
    Li Q; Yafal AG; Lee YM; Hogle J; Chow M
    J Virol; 1994 Jun; 68(6):3965-70. PubMed ID: 7514682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.